Roberto Lorusso
Latest contributions
Identifying and planning protected temporary mechanical circulatory support-based procedures in high-risk patients
21 May 2026 – From EuroPCR 2026
This session provides an in-depth update on protected temporary mechanical circulatory support-based procedures in high-risk cardiac patients. It covers patient identification criteria, device selection, and multidisciplinary planning to optimize outcomes in protected PCI, ventricular ablation, and surgical contexts.
Spectrum of cardiogenic shock
21 May 2026 – From EuroPCR 2026
This session delves into the broad spectrum of cardiogenic shock phenotypes, emphasizing the importance of selecting appropriate left ventricular support tailored to specific clinical scenarios. It offers critical insights into the timing of mechanical circulatory support and revascularisation strategies to optimize patient outcomes.
Revascularisation in patients with multivessel disease and severe left ventricular impairment
21 May 2026 – From EuroPCR 2026
This session focuses on revascularisation strategies for patients with multivessel coronary disease complicated by severe left ventricular impairment. It emphasizes patient selection criteria, the crucial role of the heart team in decision-making, and optimization of percutaneous revascularisation outcomes. The content includes comprehensive case presentations and discussions...
A Multidisciplinary Core Team
12 Jun 2025
The three Directors have different specialties: Roberto Lorusso is a cardiac surgeon, Sascha Ott a cardiac intensivist and Flavio Ribichini a interventional cardiologist. 40 other healthcare practitioners will be assigned to one of 5 working groups:
- Patient and MCS device phenotyping
- Implantation and complication management
- Shock network and patient...
Refractory heart failure: combining oral therapy and device is key
21 May 2025 – From EuroPCR 2025
Address refractory heart failure management through combined oral therapy and device interventions. This session helps identify patients needing treatment escalation, reviews contemporary cardiovascular intervention indications, and emphasizes achieving optimal synergy between pharmacologic and device-based therapies through clinical case discussions.
Left ventricle assist device for very high-risk PCI
21 May 2025 – From EuroPCR 2025
Discover the role of left ventricle assist devices in very high-risk PCI cases. This session features complex interventions combining Impella support, advanced imaging, rotational atherectomy, bifurcation and CTO techniques, and fully percutaneous ECMO-assisted procedures under local anesthesia.
Decompensated heart failure: indication and management of mechanical circulatory support
20 May 2025 – From EuroPCR 2025
This session reviews state-of-the-art strategies for managing life-threatening acute heart failure, focusing on indications and management of mechanical circulatory support, including cases like young myocarditis. Learn contemporary approaches for patients after mechanical circulatory support removal through interactive case discussions.
